diminazene and Cirrhoses, Experimental Liver

diminazene has been researched along with Cirrhoses, Experimental Liver in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Angus, PW; Burrell, LM; Herath, CB; Huang, P; Mak, KY; Rajapaksha, IG	1

Other Studies

1 other study(ies) available for diminazene and Cirrhoses, Experimental Liver

Article	Year
The small molecule drug diminazene aceturate inhibits liver injury and biliary fibrosis in mice. Scientific reports, 2018, 07-05, Volume: 8, Issue:1 Topics: Angiotensin-Converting Enzyme 2; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Cell Line; Cytokines; Diminazene; Hepatic Stellate Cells; Humans; Kupffer Cells; Liver; Liver Cirrhosis, Experimental; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidases; Peptidyl-Dipeptidase A; Reactive Oxygen Species; Renin-Angiotensin System; Treatment Outcome	2018

Article

Year

The small molecule drug diminazene aceturate inhibits liver injury and biliary fibrosis in mice.

Scientific reports, 2018, 07-05, Volume: 8, Issue:1

Topics: Angiotensin-Converting Enzyme 2; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Cell Line; Cytokines; Diminazene; Hepatic Stellate Cells; Humans; Kupffer Cells; Liver; Liver Cirrhosis, Experimental; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidases; Peptidyl-Dipeptidase A; Reactive Oxygen Species; Renin-Angiotensin System; Treatment Outcome

2018